- Country: Czech Republic
- Summary: Medicinal Products Containing Posaconazole and Ceftolozan and Beta-Lactas Inhibitor
- CZT Ref No: 117888973
- Deadline: 21 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 6287000
- Notice Type: Tender
- Document Ref. No.: 256644-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is continuous supplies of medicinal products containing Posaconazole and Ceftolozan-Sulfate and sodium salts of tazobactam for 4 years according to the current needs of the contracting authority.Current needs of the contracting authority. Part 2
The subject of the public contract is the continuous supplies of medicinal products containing Ceftolozan-Sulfate and sodium salts for 4 years according to the current needs of the client.Type: supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicinal Products Containing Posaconazole and Ceftolozan and Beta-Lactas Inhibitor - Czech Tender
The UNIVERSITY HOSPITAL HRADEC KRALOVE, a Government sector organization in Czech Republic, has announced a new tender for Medicinal Products Containing Posaconazole and Ceftolozan and Beta-Lactas Inhibitor. This tender is published on CzechTenders under CZT Ref No: 117888973 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-21.
The estimated tender value is CZK 6287000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
